GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Recbio Technology Co Ltd (FRA:G93) » Definitions » Short-Term Debt

Jiangsu Recbio Technology Co (FRA:G93) Short-Term Debt : €27.17 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jiangsu Recbio Technology Co Short-Term Debt?

Jiangsu Recbio Technology Co's Short-Term Debt for the quarter that ended in Jun. 2024 was €27.17 Mil.

Jiangsu Recbio Technology Co's quarterly Short-Term Debt increased from Jun. 2023 (€2.85 Mil) to Dec. 2023 (€5.95 Mil) and increased from Dec. 2023 (€5.95 Mil) to Jun. 2024 (€27.17 Mil).

Jiangsu Recbio Technology Co's annual Short-Term Debt increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.19 Mil) and increased from Dec. 2022 (€0.19 Mil) to Dec. 2023 (€5.95 Mil).


Jiangsu Recbio Technology Co Short-Term Debt Historical Data

The historical data trend for Jiangsu Recbio Technology Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Recbio Technology Co Short-Term Debt Chart

Jiangsu Recbio Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
- - - 0.19 5.95

Jiangsu Recbio Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only - 0.19 2.85 5.95 27.17

Jiangsu Recbio Technology Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Jiangsu Recbio Technology Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Jiangsu Recbio Technology Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Recbio Technology Co Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Jiangsu Recbio Technology Co Headlines

No Headlines